Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
Health Technology » Pharmaceuticals Major
|JNJ||Johnson & Johnson||-0.16%||162.91||0.7%||$988.77m|
|MRK||Merck & Co., Inc.||-0.11%||73.28||0.7%||$937.00m|
|LLY||Eli Lilly & Co.||-2.07%||221.72||1.1%||$592.16m|
|BMY||Bristol-Myers Squibb Co.||0.02%||59.85||1.0%||$591.86m|
|CRVS||Corvus Pharmaceuticals, Inc.||-10.17%||6.89||0.7%||$147.73m|
|RPRX||Royalty Pharma Plc||-1.43%||36.62||0.1%||$118.91m|
|APLS||Apellis Pharmaceuticals, Inc.||0.20%||35.13||0.0%||$104.57m|
180 Life Sciences Corp. develops pharmaceuticals for chronic pain and inflammatory diseases. It operates as a clinical-stage biotechnology company focused on the development of novel drugs that fulfil unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. The company was founded on September 7, 2016 and is headquartered in Palo Alto, CA.